Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

8 treatments under study, led by Sham Rf

Research Leaders

5 sponsors active, led by Al-Azhar University

Related Conditions

Often studied with 12 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (3)
Phase 2 (1)

Trial Status

Completed3
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • Sham Rf1
  • Radiofrequency Ablation Rfa1
  • Concha Bullosa Resection1
  • Partial Resection Of Inferior Turbinates Prit1
  • Radiofrequency Turbinate Reduction1

Active Sponsors

  • Al-Azhar University1
  • National Institutes of Health (NIH)1
  • University of Washington1
  • Weill Medical College of Cornell University1
  • Helsinki University Central Hospital1

Top Investigators

Related Conditions

  • Nasal Obstruction2
  • Sinusitis1
  • Adenoid Hypertrophy1
  • Sinusitis Recurrent1
  • Turbinate Hypertrophy Mucous Membrane1

Activity Timeline